Metabolic-associated fatty liver disease is less effective in predicting mortality than non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease

Zhu, Yixuan; Yeo, Yee Hui; Ma, Xiaoyan; Ni, Wenjing; Shi, Junping; Li, Jie

doi:.0..

Letter to the Editor

Metabolic-associated fatty liver disease is less effective in predicting mortality than non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease

Yixuan Zhu¹, Yee Hui Yeo², Xiaoyan Ma¹, Wenjing Ni³, Junping Shi⁴, Jie Li^1,3

¹Department of Infectious Diseases, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China
²Karsh Division of Gastroenterology and Hepatology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles 90001, California, USA
³Department of Infectious Diseases, Nanjing Drum Tower Hospital Clinical College of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China
⁴The department of Hepatology, the Affiliated Hospital & Institute of Hepatology and Metabolic Disease, Hangzhou Normal University, Hangzhou, Zhejiang, China

Correspondence :

Junping Shi ,
Email: 20131004@hznu.edu.cn
Jie Li ,
Email: lijier@nju.edu.cn

Received: June 3, 2024 Revised: June 17, 2024 Accepted: July 3, 2024
*Yixuan Zhu and Yee Hui Yeo contributed equally to this work.